Nightstar Therapeutics Companies
Nightstar Therapeutics is a biopharmaceutical company that specializes in developing gene therapies for retinal dystrophies. As a UK startup, Nightstar focuses on using gene therapy to treat rare conditions caused by mutations in a single gene. Their main goal is to provide innovative treatments for retinal dystrophies and improve the lives of patients suffering from these conditions. Nightstar has made significant achievements in the field of gene therapy and continues to advance their pipeline of potential therapies for various retinal diseases.
Headquarters:
London, England, United Kingdom
Founded Date:
2013
Employee Number:
11-50
Industry:
Advanced BioTech R&D
Technology:
Gene Therapies (disease treatment)
Number Of Exists:
Post-IPO Equity